Key result
Processing of Factor VIII concentrates resulted in an overall Hepatitis A virus clearance of > 8 log, with contributions from antibody neutralization, cryoprecipitation, and lyophilization.
Answers are grounded in this paper and cite their sources.
The production process for Factor VIII concentrates effectively clears >8 log of Hepatitis A virus, primarily through antibody neutralization, cryoprecipitation, and lyophilization.
Although hepatitis A virus (HAV) transmission by single donor blood products is a rare event, recent reports have raised concerns about the potential for HAV transmission by pooled plasma products. In this study the removal and inactivation of HAV during production of a factor VIII concentrate, which included solvent-detergent treatment and anion-exchange chromatography steps, was assessed at 5 distinct stages of production using infectivity and, in some cases, isotopic assays. The results of these 'spiking' studies revealed an overall HAV clearance of > 8 log with appreciable contributions from antibody neutralisation, cryoprecipitation, lyophilization and possibly chromatography, but not filtration. In addition it was shown that neither solvent detergent treatment or ion-exchange chromatography reversed or impeded the neutralisation of HAV by antibody.
No takes yet. Share an insight, caveat, or question.
Hamman et al. (1994) studied Hepatitis A Virus (HAV) transmission potential in pooled plasma products. Factor VIII concentrate production steps (solvent-detergent treatment, anion-exchange chromatography, cryoprecipitation, lyophilization) was evaluated on HAV clearance (> 8 log clearance). Processing of Factor VIII concentrates resulted in an overall Hepatitis A virus clearance of > 8 log, with contributions from antibody neutralization, cryoprecipitation, and lyophilization.
Synapse has enriched 10 related papers. Consider them for comparative context: